XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ DEFICIENCY (Tables)
6 Months Ended
Sep. 30, 2024
Equity [Abstract]  
SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY

A roll-forward of activity is presented below for the six months ended September 30, 2024:

 SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY

  

Fiscal Year

2025

   

Fiscal Year

2024

   $    $
Balance beginning of period – March 31   1,488,920       
Net proceeds received pursuant to the issuance of preferred shares   1,732,532     

1,900,000

 
Recognition of derivative liabilities (Note 8)   (649,533)     (642,416 )
Conversion into common shares   (285,814)    

 
Balance end of period – September 30   2,286,105     

1,257,584

 
SCHEDULE OF WARRANTS OUTSTANDING

Warrant activity during the six months ended September 30, 2024, is indicated below:

 

   Broker Warrants  

Consultant and

Noteholder

Warrants

  

Warrants Issued

on Convertible

Notes

   Total 
As at March 31, 2024   208,927    253,994    868,098    1,331,019 
                     
Expired/cancelled                
Exercised                
Issued                
As at September 30, 2024   208,927    253,994    868,098    1,331,019 
                     
Exercise Price   $ 2.09 to $22.50    $ 2.69 to $14.40   $4.18      
Expiration Date   August 2026 to October 2033    March 2029 to Dec 2032    October 2027      
SCHEDULE OF STOCK OPTION ACTIVITIES

The following table summarizes the stock option activities during the six months ended September 30:

 

   2024      2023  
  

Number of

Options

  

Weighted Average

Exercise Price

   

Number of

Options

 

Weighted Average

Exercise Price

                   
Outstanding at March 31, 2024   1,239,873   $9.39     

1,264,890

    $

9.29

 
Granted   291,559   $1.24     

3,585

    $

2.79

 
Exercised      $     

    $    
Expired   (54,219)  $12.57     

(12,035

)   $

1.61

 
Forfeited   (12,500)  $8.28     

(5,362

)   $

8.58

 
Outstanding at September 30, 2024   1,464,713   $7.71     

1,251,078

    $

9.30

 
SCHEDULE OF FAIR VALUE OF OPTION GRANTED USING VALUATION ASSUMPTIONS

The fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions, for each of the respective six months periods ended September 30:

 

  

September 30,

2024

   

September 30,

2023

 
Exercise price ($)   1.2    2.79 
Risk free interest rate (%)   4.13%    3.85 
Expected term (Years)   5.5-6.5     10.0 
Expected volatility (%)   107.7%-109.8%    117.1 
Expected dividend yield (%)   0     0.00 
Fair value of option ($)   0.689-0.733     2.30 
Expected forfeiture (attrition) rate (%)   0     0.00